oxazolidin-2-one has been researched along with cilastatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cappelletty, D; Jacobs, D | 1 |
| Butler-Laporte, G; Menzies, D; Winters, N | 1 |
1 review(s) available for oxazolidin-2-one and cilastatin
| Article | Year |
|---|---|
Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment.
Topics: Amoxicillin; Antitubercular Agents; Azithromycin; Cilastatin; Clarithromycin; Clavulanic Acid; HIV Infections; Humans; Imipenem; Isoxazoles; Macrolides; Meropenem; Mycobacterium tuberculosis; Oxazolidinones; Randomized Controlled Trials as Topic; Thienamycins; Thioridazine; Treatment Outcome; Tuberculosis, Multidrug-Resistant; World Health Organization | 2015 |
1 other study(ies) available for oxazolidin-2-one and cilastatin
| Article | Year |
|---|---|
Evaluating the impact of a pharmacist's absence from an antimicrobial stewardship team.
Topics: Acetamides; Anti-Infective Agents; Antifungal Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Microbial; Echinocandins; Guideline Adherence; Humans; Imipenem; Length of Stay; Linezolid; Lipopeptides; Medication Errors; Medication Therapy Management; Micafungin; Ohio; Oxazolidinones; Patient Care Team; Pharmacy Service, Hospital; Retrospective Studies; Workforce | 2013 |